Rachel Humphrey, M.D.

Rachel Humphrey, M.D.

DirectoratPyxis Oncology· In proxies 2023–2025

Rachel Humphrey, M.D. sits on 5 public boards.

Boards1

  • Pyxis OncologyDirector · 3 yr on the boardIndependentCompensation, Nominating and Corporate Governance, Research and Development (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Pyxis OncologyPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +57%
  2. Voro TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  3. AffibodyPublic company
    • Director? – PresentNo stock prices for these years
  4. Sporos BiosciencesPublic company
    • Director? – PresentNo stock prices for these years
  5. XilioPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?